Kainzwaldner V, Rachinger-Adam B, Mioc-Curic T, Wöhrle T, Hinske L C, Luchting B, Ewert T, Azad S C
Klinik für Anästhesiologie, LMU-Klinikum Großhadern, Marchioninistr. 15, 81377 München, Deutschland.
Anaesthesist. 2013 Jun;62(6):453-9. doi: 10.1007/s00101-013-2177-7. Epub 2013 May 15.
Despite well-designed concepts of perioperative pain management, recent studies have revealed that a large number of patients still suffer from unacceptable pain after surgery. The purpose of this prospective evaluation was to critically analyze postoperative pain treatment provided by a routinely established, DIN certified acute pain service (APS) at the University Hospital Großhadern in Munich.
A total of 1,000 consecutive patients received one of the following analgesic procedures: continuous epidural analgesia (EA, n = 401), continuous and patient-controlled epidural analgesia (PCEA, n = 305), intravenous patient-controlled analgesia with opioids (PCA, n = 169) or continuous peripheral nerve block (CPNB, n = 125). For EA and PCEA, ropivacaine 0.2 % and sufentanil 0.24 µg/ml were administered while peripheral regional analgesia was performed with infusion of ropivacaine 0.2 % only. Patients with PCEA were allowed a 3 mg bolus once per hour on demand. Standardized intravenous PCA was performed with piritramide 2.5 mg/ml, a bolus of 2.5 mg, a lock-out time of 15 min, a maximum of 25 mg/4 h and no background infusion. During the daily visits the APS assessed pain intensity at rest and during movement on a numerical rating scale from 0 (no pain) to 10 (maximum pain), acceptance of pain, satisfaction with the analgesic procedure, demand of additional non-opioid analgesics, the need for optimization including bolus applications and changes of the infusion rate or retraction of the epidural catheter. The duration of the procedures, side effects and complications were documented. The catheter insertion sites were inspected daily for redness and tenderness on palpation.
In general, epidural and peripheral regional analgesic techniques were superior in terms of postoperative analgesia to intravenous opioid PCA and were associated with fewer side effects, such as sedation, nausea, vomiting, obstipation and sensorimotor deficits. A subgroup analysis revealed that in major upper abdominal surgery, EA provided significantly better analgesia at rest and during movement than PCA. In lower abdominal surgery PCEA induced significantly better analgesia than both PCA and EA, especially during movement. Patient satisfaction was generally high and was best with PCEA (95 %) followed by CPNB (94 %), EA (91 %) and PCA (88 %). On the first postoperative day analgesic procedures had to be optimized (e.g. by bolus administration, retraction of catheters or changes to standardized PCA) in 23 % of EA patients, 10 % of PCEA patients, 6 % of PCA patients and 12 % of CPNB patients. Major complications, such as neuraxial hematoma, infections or respiratory depression were not observed.
As described in many prospective studies, this evaluation revealed that for postoperative pain control, regional anesthesia is superior to intravenous patient-controlled analgesia with strong opioids in terms of analgesia and side effects. In the setting of a well-organized acute pain service with frequent education and training of all members involved, postoperative pain management is safe and effective. However, regular re-evaluation of the defined and certified procedures is necessary.
尽管围手术期疼痛管理的概念设计良好,但最近的研究表明,仍有大量患者术后遭受难以接受的疼痛。本前瞻性评估的目的是严格分析慕尼黑大学格罗斯哈登医院常规设立的、符合德国工业标准(DIN)认证的急性疼痛服务(APS)所提供的术后疼痛治疗。
共有1000例连续患者接受了以下镇痛方法之一:持续硬膜外镇痛(EA,n = 401)、持续及患者自控硬膜外镇痛(PCEA,n = 305)、静脉注射阿片类药物患者自控镇痛(PCA,n = 169)或连续外周神经阻滞(CPNB,n = 125)。对于EA和PCEA,给予0.2%的罗哌卡因和0.24μg/ml的舒芬太尼,而外周区域镇痛仅给予0.2%的罗哌卡因输注。PCEA患者按需每小时可给予一次3mg的推注剂量。标准化静脉PCA使用2.5mg/ml的匹米诺定,单次推注剂量为2.5mg,锁定时间为15分钟,最大剂量为25mg/4小时,且无背景输注。在每日查房时,APS使用从0(无疼痛)至10(最大疼痛)的数字评分量表评估静息和活动时的疼痛强度、对疼痛的接受程度、对镇痛方法的满意度、对额外非阿片类镇痛药的需求、包括推注应用、输注速率改变或硬膜外导管拔除在内的优化需求。记录各方法的持续时间、副作用和并发症。每天检查导管插入部位有无发红和触痛。
总体而言,硬膜外和外周区域镇痛技术在术后镇痛方面优于静脉注射阿片类药物PCA,且副作用较少,如镇静、恶心、呕吐、便秘和感觉运动功能障碍。亚组分析显示,在中上腹部大手术中,EA在静息和活动时提供的镇痛效果明显优于PCA。在下腹部手术中,PCEA诱导的镇痛效果明显优于PCA和EA,尤其是在活动时。患者总体满意度较高,PCEA最佳(95%),其次是CPNB(94%)、EA(91%)和PCA(88%)。在术后第一天,23%的EA患者、10%的PCEA患者、6%的PCA患者和12%的CPNB患者需要对镇痛方法进行优化(如通过推注给药、拔除导管或改为标准化PCA)。未观察到严重并发症,如椎管内血肿、感染或呼吸抑制。
如许多前瞻性研究所述,本评估显示,对于术后疼痛控制,区域麻醉在镇痛和副作用方面优于静脉注射强效阿片类药物的患者自控镇痛。在一个组织良好、对所有相关成员进行频繁教育和培训的急性疼痛服务机构中,术后疼痛管理是安全有效的。然而,有必要对既定的和经过认证的程序进行定期重新评估。